Anika Therapeutics (ANIK) vs OraSure Technologies (OSUR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Anika Therapeutics (ANIK) has outperformed OraSure Technologies (OSUR) over the past year, gaining 108.1% versus a gain of 17.1%. Over five years, ANIK leads with a -53.8% price change compared with -63.9% for OSUR. OraSure Technologies is the larger company by market cap ($261.7 million vs $257.4 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ANIK | OSUR |
|---|---|---|
| Share price | $19.23 | $3.80 |
| Market cap | $257.35M | $261.74M |
| 1-day change | -1.54% | +1.74% |
| YTD return | +100.10% | +56.82% |
| 1-year return | +108.12% | +17.13% |
| 5-year return | -53.84% | -63.89% |
| Forward P/E | 20.24 | — |
| EPS (TTM) | $-0.23 | $-0.69 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $22.88 | $4.58 |
| 52-week low | $8.67 | $2.08 |
| Distance from 52-week high | -15.95% | -17.14% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +19.60% | +5.40% |
| Average volume | 98.57K | 484.72K |
| Shares outstanding | 13.38M | 68.97M |
| Employees | 235 | 500 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ANIK has outperformed OSUR by 91.0 percentage points over the past year.
About Anika Therapeutics
ANIK stock →Anika Therapeutics, Inc., a joint preservation company, focuses on early intervention orthopedics in the United States, Europe, and internationally. The company offers osteoarthritis (OA) pain management products and services, such as Monovisc and Orthovisc, which are single- and multi-injection, HA viscosupplement products indicated for pain relief from OA conditions, as well as Cingal, a non-opioid, single-injection OA pain management product; regenerative solutions, including an HA-based scaffold with bone and tendon fixation components and arthroscopic delivery instruments; Hyalofast, a resorbable scaffold used for single stage cartilage regeneration; and Tactoset injectable bone substitute, an HA-enhanced injectable bone repair therapy designed to treat insufficiency fractures and augment hardware fixation.
Health Care · Medical/Dental Instruments · 235 employees
About OraSure Technologies
OSUR stock →OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, sells, and distributes diagnostic products and specimen collection devices in the United States, Europe, Africa, and internationally. It offers OraQuick Rapid HIV test, OraQuick HIV self-test, OraQuick HIV self-test(international), OraQuick HCV rapid antibody test and self-test, Syphilis health check rapid diagnostic test, OraQuick Ebola rapid antigen test, InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, SickleSCAN test, and OraSure oral fluid collection device for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D.
Health Care · Medical/Dental Instruments · 500 employees
ANIK vs OSUR FAQ
Which is bigger, Anika Therapeutics or OraSure Technologies?
OraSure Technologies (OSUR) is larger, with a market capitalization of $261.74M compared with $257.35M for Anika Therapeutics (ANIK).
Which stock has performed better over the past year, ANIK or OSUR?
ANIK returned +108.12% over the past 12 months, compared with +17.13% for OSUR (price return, excluding dividends). Past performance does not predict future results.
Are Anika Therapeutics and OraSure Technologies in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.